Date published: 2025-10-28

1-800-457-3801

SCBT Portrait Logo
Seach Input

FLJ21062 Inhibitors

FLJ21062 inhibitors represent a distinct chemical class specifically designed to interact with and inhibit the activity of the FLJ21062 protein. The inhibitory action of these compounds is highly targeted, affecting the FLJ21062 protein's function by disrupting its specific signaling pathways and biological processes. Each inhibitor within this class is characterized by its chemical structure and mode of action, which directly correlates with the reduction in FLJ21062 activity. The inhibitors may achieve this by binding to the active site of the protein, preventing its interaction with substrates or cofactors essential for its function. Alternatively, they may interact with regulatory regions of the protein, altering its conformation and thereby impeding its activity. The precision of these inhibitors lies in their ability to selectively influence the FLJ21062 protein without broadly affecting other proteins or pathways. This specificity ensures a targeted approach to inhibition, where only the pathways involving FLJ21062 are affected.

The biochemical pathways influenced by FLJ21062 inhibitors are integral to understanding their mechanism of action. While the exact biological role of FLJ21062 may encompass a range of functions, the inhibitors are designed to impact the protein's contribution to these pathways negatively. By doing so, they effectively reduce the functional output of FLJ21062, leading to a decrease in its associated activities. The chemical compounds within this class are varied, yet they share the common feature of having a significant influence on the protein's activity. The complex interaction between FLJ21062 inhibitors and the protein's signaling pathways exemplifies the intricate nature of protein function regulation within the cell. These inhibitors are crucial tools for probing the biological role of FLJ21062 and offer insights into the fine-tuning of cellular processes that are mediated by this specific protein.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$25.00
$117.00
$209.00
27
(1)

Imatinib is a tyrosine kinase inhibitor specifically targeting BCR-ABL, c-Kit, and PDGFR. If the activity of FLJ21062 is associated with signaling pathways that involve these kinases, Imatinib would indirectly decrease FLJ21062 activity by inhibiting these pathways.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

Sorafenib is a kinase inhibitor that targets several receptor tyrosine kinases such as VEGFR and PDGFR, and the Raf kinases within the MAPK pathway. This broad inhibition of kinases would lead to a reduction in FLJ21062 activity if it relies on these kinases for activation.